Is a complete HNGE research report available?

No complete published report is available for Hinge Health, Inc. (HNGE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Hinge Health, Inc. (HNGE)

NYSE: HNGE · USD

$115

+1.33 (+1.2%)· Recorded snapshot

Market cap	9.3B
Revenue (ttm)	720.1M
Net income (ttm)	107.3M
EPS (ttm)	$1.34
Shares out	80.7M
P/E (trailing)	86.3x
P/E (forward)	44.5x
Volume	684,932

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 720.1M
Net income (ttm): 107.3M
EPS (ttm): $1.34
P/E (trailing): 86.3x
P/E (forward): 44.5x
Market cap: 9.3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Metric	Value
Amount currency	USD
CIK code	0001673743
Company name	Hinge Health, Inc.
Country	United States
Country code	US
CUSIP number	433313103
Earnings date	2026-11-02
Earnings time	amc
Employees	1,437
Enterprise value	$8.8B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2012
In index	RUSSELL2000
Industry	Health Information Services
IPO date	2025-05-22
Is primary listing	Yes
Is SPAC	No
ISIN number	US4333131039
Last 10-K release date	2026-03-03
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$9.3B
Market cap category	Mid-Cap
Next earnings date	2026-11-02
Options	Yes
Price	$115.23
Price currency	USD
Sector	Healthcare
SIC code	7374
Stock price date	2026-10-28
Symbol	HNGE
U.S. state	California
Website	https://www.hingehealth.com

Metric

Value

Amount currency

USD

CIK code

0001673743

Company name

Hinge Health, Inc.

Country

United States

Country code

CUSIP number

433313103

Earnings date

2026-11-02

Earnings time

amc

Employees

1,437

Enterprise value

$8.8B

Exchange

NYSE

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2012

In index

RUSSELL2000

Industry

Health Information Services

IPO date

2025-05-22

Is primary listing

Yes

Is SPAC

ISIN number

US4333131039

Last 10-K release date

2026-03-03

Last earnings date

2026-08-04

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$9.3B

Market cap category

Mid-Cap

Next earnings date

2026-11-02

Options

Yes

Price

$115.23

Price currency

USD

Sector

Healthcare

SIC code

7374

Stock price date

2026-10-28

Symbol

HNGE

U.S. state

California

Website

https://www.hingehealth.com

Metric	Value
Adjusted P/E ratio	58.52x
Earnings yield	1.16%
EV/Earnings	82.04x
EV/EBIT	93.96x
EV/EBITDA	91.98x
EV/FCF	30.34x
EV/Sales	12.22x
FCF / EV yield	3.3%
FCF yield	3.13%
Forward EV/Sales	9.03x
Forward P/E	44.55x
Forward P/S	9.51x
Graham number	11.35623
Graham upside	-90.11%
Industry forward P/E	35.4x
P/(FCF - SBC) ratio	44.71x
P/(OCF - SBC) ratio	44.57x
P/B ratio	26.53x
P/E ratio	86.31x
P/FCF ratio	31.95x
P/OCF ratio	31.88x
P/S ratio	12.87x
PEG ratio	0.44x
Price / tangible book value	33.32x
Price/EBITDA ratio	96.87x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Adjusted P/E ratio

58.52x

Earnings yield

1.16%

EV/Earnings

82.04x

EV/EBIT

93.96x

EV/EBITDA

91.98x

EV/FCF

30.34x

EV/Sales

12.22x

FCF / EV yield

3.3%

FCF yield

3.13%

Forward EV/Sales

9.03x

Forward P/E

44.55x

Forward P/S

9.51x

Graham number

11.35623

Graham upside

-90.11%

Industry forward P/E

35.4x

P/(FCF - SBC) ratio

44.71x

P/(OCF - SBC) ratio

44.57x

P/B ratio

26.53x

P/E ratio

86.31x

P/FCF ratio

31.95x

P/OCF ratio

31.88x

P/S ratio

12.87x

PEG ratio

0.44x

Price / tangible book value

33.32x

Price/EBITDA ratio

96.87x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	13.01%
EBITDA margin	13.29%
Effective tax rate	1.69%
FCF margin	40.29%
Gross margin	84.54%
Operating margin	13.01%
Pretax margin	15.41%
Profit margin	15.15%
Profit per employee	$74,659
Profitable quarters	3
Revenue per employee	$501,086
ROA	7.7%
ROCE	27.08%
ROE	30.38%
ROIC	15.96%
SBC / revenue	11.5%
Tax / revenue	0.26%

Metric

Value

EBIT margin

13.01%

EBITDA margin

13.29%

Effective tax rate

1.69%

FCF margin

40.29%

Gross margin

84.54%

Operating margin

13.01%

Pretax margin

15.41%

Profit margin

15.15%

Profit per employee

$74,659

Profitable quarters

Revenue per employee

$501,086

ROA

7.7%

ROCE

27.08%

ROE

30.38%

ROIC

15.96%

SBC / revenue

11.5%

Tax / revenue

0.26%

Metric	Value
EPS growth (QoQ)	25.79%
EPS growth quarters	1
EPS growth years	0
FCF growth	218.23%
FCF growth (Q)	405.74%
FCF growth (QoQ)	135.56%
Gross profit growth	62.36%
Gross profit growth (Q)	86.5%
Net income growth (QoQ)	26.73%
Net income growth quarters	1
Net income growth years	0
OCF growth	216.46%
OCF growth (Q)	401.42%
OCF growth (QoQ)	135.39%
Revenue growth	49.77%
Revenue growth (Q)	53%
Revenue growth (QoQ)	16.74%
Revenue growth quarters	6
Revenue growth years	2

Metric

Value

EPS growth (QoQ)

25.79%

EPS growth quarters

EPS growth years

FCF growth

218.23%

FCF growth (Q)

405.74%

FCF growth (QoQ)

135.56%

Gross profit growth

62.36%

Gross profit growth (Q)

86.5%

Net income growth (QoQ)

26.73%

Net income growth quarters

Net income growth years

OCF growth

216.46%

OCF growth (Q)

401.42%

OCF growth (QoQ)

135.39%

Revenue growth

49.77%

Revenue growth (Q)

53%

Revenue growth (QoQ)

16.74%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-666,000
Depreciation and amortization	$2M
EBIT	$93.7M
EBITDA	$95.7M
EPS	$1.34
FCF per share	$3.60
Financing cash flow	$-222.3M
Free cash flow	$290.1M
Free cash flow minus SBC	$207.3M
Gross profit	$608.7M
Income taxes	$1.9M
Investing cash flow	$-19.8M
Net cash flow	$48.7M
Net income	$107.3M
Operating cash flow minus SBC	$208M
Operating income	$93.7M
Revenue	$720.1M
Stock-based compensation	$82.8M

Metric

Value

Capital expenditures

$-666,000

Depreciation and amortization

$2M

EBIT

$93.7M

EBITDA

$95.7M

EPS

$1.34

FCF per share

$3.60

Financing cash flow

$-222.3M

Free cash flow

$290.1M

Free cash flow minus SBC

$207.3M

Gross profit

$608.7M

Income taxes

$1.9M

Investing cash flow

$-19.8M

Net cash flow

$48.7M

Net income

$107.3M

Operating cash flow minus SBC

$208M

Operating income

$93.7M

Revenue

$720.1M

Stock-based compensation

$82.8M

Metric	Value
Altman Z-Score	4.61
Book value per share	$4.29
Debt / EBITDA	0.06
Debt / equity	0.02
Debt / FCF	0.02
Goodwill	$64.1M
Long-term assets	$184M
Long-term liabilities	$1.6M
Net cash (debt)	$468.2M
Net cash / market cap	5.05%
Net cash growth	16.11%
Net debt / EBITDA	-4.89
Net debt / equity	-1.36
Net debt / FCF	-1.61
Piotroski F-Score	5
Property, plant and equipment	$17.8M
Shareholders' equity	$344.3M
Tangible book value	$278.2M
Tangible book value per share	$3.47
Total assets	$827.4M
Total cash	$389.4M
Total debt	$5.9M
Total liabilities	$483.1M

Metric

Value

Altman Z-Score

4.61

Book value per share

$4.29

Debt / EBITDA

0.06

Debt / equity

0.02

Debt / FCF

0.02

Goodwill

$64.1M

Long-term assets

$184M

Long-term liabilities

$1.6M

Net cash (debt)

$468.2M

Net cash / market cap

5.05%

Net cash growth

16.11%

Net debt / EBITDA

-4.89

Net debt / equity

-1.36

Net debt / FCF

-1.61

Piotroski F-Score

Property, plant and equipment

$17.8M

Shareholders' equity

$344.3M

Tangible book value

$278.2M

Tangible book value per share

$3.47

Total assets

$827.4M

Total cash

$389.4M

Total debt

$5.9M

Total liabilities

$483.1M

Metric	Value
Asset turnover	0.95
Current assets	$643.4M
Current liabilities	$481.4M
Current ratio	1.34
Inventory turnover	7.24
Net working capital	$-223.2M
Quick ratio	1.07
Working capital	$161.9M
Working capital turnover	3.23

Metric

Value

Asset turnover

0.95

Current assets

$643.4M

Current liabilities

$481.4M

Current ratio

1.34

Inventory turnover

7.24

Net working capital

$-223.2M

Quick ratio

1.07

Working capital

$161.9M

Working capital turnover

3.23

Metric	Value
Buyback yield / dilution	-267.86%
Dividend yield	0%
Shareholder yield	-267.86%

Metric

Value

Buyback yield / dilution

-267.86%

Dividend yield

Shareholder yield

-267.86%

Metric	Value
150-day SMA	$74.82
1D price change	1.17%
1M price change	20.22%
1M total return	20.22%
1W price change	6.86%
1W total return	6.86%
1Y price change	130.38%
1Y return CAGR	130.51%
1Y total return	130.38%
20-day SMA	$104.78
200-day SMA	$66.35
3M price change	52.96%
3M total return	52.96%
50-day SMA	$97.02
50-day SMA vs 200-day SMA	50over200
52-week high	$116.00
52-week high date	2026-10-28
52-week low	$30.08
52-week low date	2026-02-09
6M price change	155.14%
6M total return	155.14%
All-time high	$116.00
All-time high date	2026-10-28
All-time low	$30.08
All-time low date	2026-02-09
Average true range (ATR)	$4.22
Average volume	1.7M
Beta (1Y)	1.57
Beta (2Y)	1.69
Change from 52-week high	-0.66%
Change from 52-week low	283.08%
Change from all-time high	-0.96%
Change from all-time low	281.95%
Change from open	2.02%
Day's gap	-0.83%
Dollar volume	$78.9M
High price	$116.00
Low price	$112.95
Monthly RSI	71.77
Open price	$112.95
Position in 52-week range	74.75%
Premarket change	-0.31%
Premarket close	$113.90
Premarket price	$113.55
Previous close	$113.90
Price vs 150-day SMA	53.55%
Price vs 20-day SMA	9.65%
Price vs 200-day SMA	73.15%
Price vs 50-day SMA	18.42%
Relative volume	0.39
Return from IPO open	192.68%
Return from IPO price	258.98%
RSI	72.39
Sharpe ratio	1.75
Sortino ratio	2.93
Volume	684.9K
Weekly RSI	76.48
YTD price change	147.34%
YTD total return	147.34%

Metric

Value

150-day SMA

$74.82

1D price change

1.17%

1M price change

20.22%

1M total return

20.22%

1W price change

6.86%

1W total return

6.86%

1Y price change

130.38%

1Y return CAGR

130.51%

1Y total return

130.38%

20-day SMA

$104.78

200-day SMA

$66.35

3M price change

52.96%

3M total return

52.96%

50-day SMA

$97.02

50-day SMA vs 200-day SMA

50over200

52-week high

$116.00

52-week high date

2026-10-28

52-week low

$30.08

52-week low date

2026-02-09

6M price change

155.14%

6M total return

155.14%

All-time high

$116.00

All-time high date

2026-10-28

All-time low

$30.08

All-time low date

2026-02-09

Average true range (ATR)

$4.22

Average volume

1.7M

Beta (1Y)

1.57

Beta (2Y)

1.69

Change from 52-week high

-0.66%

Change from 52-week low

283.08%

Change from all-time high

-0.96%

Change from all-time low

281.95%

Change from open

2.02%

Day's gap

-0.83%

Dollar volume

$78.9M

High price

$116.00

Low price

$112.95

Monthly RSI

71.77

Open price

$112.95

Position in 52-week range

74.75%

Premarket change

-0.31%

Premarket close

$113.90

Premarket price

$113.55

Previous close

$113.90

Price vs 150-day SMA

53.55%

Price vs 20-day SMA

9.65%

Price vs 200-day SMA

73.15%

Price vs 50-day SMA

18.42%

Relative volume

0.39

Return from IPO open

192.68%

Return from IPO price

258.98%

RSI

72.39

Sharpe ratio

1.75

Sortino ratio

2.93

Volume

684.9K

Weekly RSI

76.48

YTD price change

147.34%

YTD total return

147.34%

Metric	Value
Float	50.6M
Float percentage	62.73%
Shares change (QoQ)	1.25%
Shares change (YoY)	267.86%
Shares held by insiders	17.02%
Shares held by institutions	81.64%
Shares outstanding	80.7M
Short % of float	12.51%
Short % of shares	7.85%
Short ratio	3.4 days

Metric

Value

Float

50.6M

Float percentage

62.73%

Shares change (QoQ)

1.25%

Shares change (YoY)

267.86%

Shares held by insiders

17.02%

Shares held by institutions

81.64%

Shares outstanding

80.7M

Short % of float

12.51%

Short % of shares

7.85%

Short ratio

3.4 days

Hinge Health, Inc. (HNGE)

Price

Financial snapshot

Fair-value bridge

Latest news · HNGE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HNGE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on HNGE

Frequently asked questions